mroithmayr.bsky.social
@mroithmayr.bsky.social
mailchi.mp/alzdiscovery... The times they are a chang’n:
Momentum In New Blood Tests Builds with FDA Clearance of Roche Test for Primary Care
mailchi.mp
October 16, 2025 at 2:24 PM
mailchi.mp/alzdiscovery... The times they are a chang’n:
This is what scientific leadership looks like…Former CDC Director Tom Frieden on the simple steps that can prevent dementia.
October 11, 2025 at 10:07 PM
This is what scientific leadership looks like…Former CDC Director Tom Frieden on the simple steps that can prevent dementia.
She’s brilliant.
Congratulations to our friend and partner Anne White, who has been named one of Endpoints News’ Women in Biopharma 2025. Anne’s impact and leadership at @elilillyandcompany.bsky.social from advancing oncology to Alzheimer’s breakthroughs continues to transform the field.
bit.ly/3INh5wG
bit.ly/3INh5wG
Meet 20 women reshaping biopharma, from early discovery to patient advocacy
A project highlighting women in biopharma has grown since 2019, now honoring over 140 women who've shaped the industry through work on rare diseases, IPOs, AI drug discovery and patient advocacy. Desp...
endpoints.news
October 9, 2025 at 12:28 PM
She’s brilliant.
Imagine that blood tests predicting your risk of Alzheimer’s. With FDA approval and CMS reimbursements—stay tuned!
Today, our partners C2N Diagnostics submitted the #PrecivityAD2 blood test to the #FDA for approval, enabling earlier diagnosis and intervention for Alzheimer's treatment, a core tenet of the ADDF's DxA. The next frontier is precision medicine. bit.ly/46Lw4yV
October 1, 2025 at 5:28 PM
Imagine that blood tests predicting your risk of Alzheimer’s. With FDA approval and CMS reimbursements—stay tuned!